|
CAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.954100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.162080E-02 |
| Normal-vs-Stage2 |
2.564800E-01 |
| Normal-vs-Stage3 |
3.511600E-01 |
| Normal-vs-Stage4 |
3.172600E-01 |
| Stage1-vs-Stage2 |
4.568400E-01 |
| Stage1-vs-Stage3 |
1.475450E-01 |
| Stage1-vs-Stage4 |
2.899200E-01 |
| Stage2-vs-Stage3 |
7.514400E-01 |
| Stage2-vs-Stage4 |
8.810600E-01 |
| Stage3-vs-Stage4 |
8.643200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.781550E-02 |
| Normal-vs-AfricanAmerican |
2.584600E-01 |
| Normal-vs-Asian |
1.561210E-01 |
| Caucasian-vs-AfricanAmerican |
2.535300E-03 |
| Caucasian-vs-Asian |
1.756010E-01 |
| AfricanAmerican-vs-Asian |
2.110300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.946000E-02 |
| Normal-vs-Female |
3.855500E-02 |
| Male-vs-Female |
6.224600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.041800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.873600E-02 |
| Normal-vs-Age(61-80Yrs) |
7.698400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.012800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.332200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.575200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.773600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.966600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.310440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.059800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.192250E-02 |
| Normal-vs-Grade 2 |
7.599300E-03 |
| Normal-vs-Grade 3 |
2.891600E-01 |
| Normal-vs-Grade 4 |
3.664600E-01 |
| Grade 1-vs-Grade 2 |
2.904600E-01 |
| Grade 1-vs-Grade 3 |
9.897500E-02 |
| Grade 1-vs-Grade 4 |
7.793800E-02 |
| Grade 2-vs-Grade 3 |
3.356000E-02 |
| Grade 2-vs-Grade 4 |
2.537200E-01 |
| Grade 3-vs-Grade 4 |
8.592400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.09889999999558E-05 |
| Normal-vs-ccB subtype |
3.758400E-01 |
| ccA subtype-vs-ccB subtype |
1.241540E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.018500E-02 |
| Normal-vs-N1 |
2.018000E-01 |
| N0-vs-N1 |
4.552200E-01 |
|
|
